FU 6.4yrs(mean)?•?高转运者(142APD, 486CAPD)?•?APD组年龄更轻,白种人更多,糖尿病更少,在大中心治疗的比例更少;腹膜转运类型和CAPD组无差异РCAPDРAPDРCAPDРAPDР生存率Р技术生存率Рtechnique survivalРGroupРPatient survivalРTechnique survivalРUnivariate HR(95%CI)РMultivariate HR(95%CI)РUnivariate HR(95%CI)РMultivariate HR(95%CI)РHighР0.57(0.35-0.94)Р0.56(0.35-0.87)Р0.93(0.67–1.28)Р0.88(0.64–1.21)РHigh-AР0.98(0.72-1.34)Р1.08(0.81-1.45)Р1.16(0.95–1.40)Р1.17(0.95–1.44)РLow-AР0.70(0.46-1.07)Р0.98(0.66-1.45)Р0.99(0.75–1.33)Р1.02(0.77–1.35)РLowР2.21(1.24-3.93)Р2.19(1.02-4.70)Р1.35(0.79–2.28)Р1.24(0.67–2.29)РNephrol Dial Trans-plant. 2010;25:1973-1979Р进一步的病例对照分析显示:在年龄,糖尿病和种族匹配后,Р高R转es运ults患o者f in接ten受tion-to-t治rea疗t C仍ox然pr降op低ort了ion总al 体ha死zar亡ds风m险odel analysesРof the relative haAzaPrDd of APD versus CAPD for patient surv(HivaRl a0n.d60,Р95% CI 0.36–0.96)